aspirin has been researched along with lutein in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, NL; Bottle, SE; Fairfull-Smith, KE; Jensen, RT; Moody, TW; Rayner, CL; Ridnour, LA; Thomas, K; Tong, J; Wink, DA | 1 |
| Buring, JE; Gaziano, JM; Liu, S; Manson, JE; Pradhan, AD; Sesso, HD; Wang, L | 1 |
| Fischer, T | 1 |
2 review(s) available for aspirin and lutein
| Article | Year |
|---|---|
Ophthalmology. What you can do to protect your eyes.
Topics: Alcohol Drinking; Aspirin; Eye Injuries; Eye Protective Devices; Fibrinolytic Agents; Glaucoma; Humans; Hypertension; Lutein; Macular Degeneration | 2001 |
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls | 2015 |
2 other study(ies) available for aspirin and lutein
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Nitrogen Oxides; Oxidative Stress; Reactive Oxygen Species; Structure-Activity Relationship | 2018 |
Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women.
Topics: Aged; Aspirin; beta Carotene; Carotenoids; Case-Control Studies; Cryptoxanthins; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Incidence; Logistic Models; Lutein; Lycopene; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Surveys and Questionnaires; United States; Xanthophylls; Zeaxanthins | 2006 |